(13) reported that the proportion of CD177+ in ovarian cancer epithelial tissue was increased significantly and exhibited a positive correlation with tumor differentiation, tumor diameter, tumor stage, and sensitivity to platinum-based chemotherapy. This evidence concerns the gene CD177 and ovarian carcinoma.